Coronary Endothelial Vasomotor Function and Vascular Remodeling in Heart Transplant Recipients Randomized for Tacrolimus or Cyclosporine Immunosuppression

Journal of the American College of Cardiology

Volumn 47, Issue 8, 2006, Pages 1622-1629

  Petrakopoulou, Paraskevi ^a   Anthopoulou, Lydia ^a   Muscholl, Michael ^a   Klauss, Volker ^b   von Scheidt, Wolfgang ^c   Überfuhr, Peter ^b   Meiser, Bruno M ^b   Reichart, Bruno ^b   Weis, Michael ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c KLINIKUM AUGSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DILTIAZEM; ENALAPRIL; ENDOTHELIN 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAMIPRIL; TACROLIMUS;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CARDIAC ALLOGRAFT VASCULOPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VASOMOTOR REFLEX;

ADULT; AGED; BLOOD FLOW VELOCITY; CORONARY CIRCULATION; CORONARY VESSELS; CYCLOSPORINE; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PERICARDIUM; TACROLIMUS; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL; VASOMOTOR SYSTEM;

EID: 33646035208     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.10.073     Document Type: Article

References (26)

1. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., and Novick R.J. The Registry of the International Society for Heart and Lung Transplantation. eighteenth official report. J Heart Lung Transplant 20 (2001) 805-815
2. Weis M., and von Scheidt W. Coronary artery disease in the transplanted heart. Annu Rev Med 51 (2000) 81-100
3. Hollerberg S.M., Klein L.W., Parillo J.E., et al. Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation 104 (2001) 3091-3096
4. Fitzgerald P.J., St Goar F.G., Connolly A.J., et al. Intravascular ultrasound imaging of coronary arteries. is three layers the norm?. Circulation 86 (1992) 154-158
5. Moien-Afshari F., McManus B.M., and Laher I. Immunosuppression and transplant vascular disease. benefit and adverse effects. Pharmacol Ther 100 (2003) 141-156
6. Keogh A. Calcineurin inhibitors in heart transplantation. J Heart Lung Transplant 23 Suppl (2004) S202-S206
7. Bobik A., Grooms A., Millar J.A., and Grinpuckel S. Growth factor activity of endothelium vascular smooth muscle. Am J Physiol 258 (1990) C408-C415
8. Haas G.J., Wooding-Scott M., Binkley P.F., Mzerowity P.D., Kellez R., and Cody R.S. Effects of successful cardiac transplantation on plasma endothelin. J Am Coll Cardiol 71 (1993) 237-240
9. Weis M., Wildhirt S.M., Schulze C., Rieder G., Wilbert-Lampen U., and Wolf P.W. Endothelin in coronary endothelial dysfunction after human heart transplantation. J Heart Lung Transplant 18 (1999) 1071-1079
10. Weis M., Wildhirt S.M., Schulze C., et al. Coronary vasomotor dysfunction in the cardiac allograft. impact of different immunosuppressive regimens. J Cardiovasc Pharmacol 36 (2000) 776-784
11. Petrakopoulou P., Kuebrich M., Pehlivanli S., Meiser B., Reichart B., von Scheidt W., and Weis M. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Circulation 110 Suppl II (2004) II207-II212
12. Doucette J.W., Corl P.D., Payne H.M., et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 85 (1992) 1899-1911
13. Weis M., Pehlivanli S., Meiser B., and von Scheidt W. Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation. J Am Coll Cardiol 38 (2001) 814-818
14. Pham S.M., Kormos R.L., Hattler B.G., Kawai A., Tsamandas A.C., and Demetris A.J. A prospective trial of Tac (FK506) in clinical heart transplantation. intermediate-term results. J Thorac Cardiovasc Surg 111 (1996) 764-772
15. Meiser B.M., Groetzner J., Kaczmarek I., et al. Tacrolimus or cyclosporine. which is the better partner for mycophenolate mofetil in heart transplant recipients?. Transplantation 8 (2004) 591-598
16. Auch-Schwelk W., Bossaller C., Gotze S., Thelen J., and Fleck E. Endothelial and vascular smooth muscle functions after chronic treatment with CyA A. J Cardiovasc Pharmacol 21 (1993) 435-440
17. Oflaz H., Turkmen A., Kayancioglu R., et al. The effect of calcineurin inhibitors on entorhinal function in renal transplant recipients. Clin Transplant 17 (2003) 212-216
18. Weis M., Pehlivanli S., and von Scheidt W. Vasodilator response to nifedipine in human coronary arteries with endothelial dysfunction. J Cardiovasc Pharmacol 39 (2002) 172-180
19. Weis M., Wildhirt S.M., Schulze C., et al. Coronary vasomotor dysfunction in the cardiac allograft. impact of different immunosuppressive regimens. J Cardiovasc Pharmacol 36 (2000) 776-784
20. Klauss V., Konig A., Spes C., et al. Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy. Am J Cardiol 85 (2000) 266-269
21. Wilasrusmee C., Da Silva M., Singh B., et al. Morphological and biochemical effects of the immunosuppressive drugs in a capillary tube assay for endothelial dysfunction. Clin Transplant 17 Suppl 9 (2003) 6-12
22. Wilasrusmee C., Da Silva M., Siddiqui J., Bruch D., Kittur S., and Wilasrusmee S. Role of ET-1 in microvascular dysfunction caused by Cyclosporin A. J Am Coll Surg 196 (2003) 584-591
23. Waller J.R., Murphy G.J., Bicknell G.R., Toomey D., and Nicholson M.L. Effects of the combination of rapamycin with Tac or cyclosporin on experimental hyperplasia. Br J Surg 89 (2002) 1390-1395
24. Eisen H.J., Tuzcu E.M., Dorent R., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349 (2003) 829-830
25. Yatscoff R.W., Fryer J., and Thliveris J.A. Comparison of the effect of rapamycin and FK506 on release of prostacyclin and endothelin in vitro. Clin Biochem 26 (1993) 409-414
26. Trapp A., and Weis M. The impact of immunosuppression on endothelial function. J Cardiovasc Pharmacol 45 (2005) 81-87